Research Interests

YGYu Gu
Papers(2)
Clinical characterist…Expression of B7 fami…
Collaborators(4)
Yang XiangJie ChenLiju ZongShuangni Yu
Institutions(1)
Chinese Academy Of Me…

Papers

Clinical characteristics and oncological outcomes of recurrent adult granulosa cell tumor of ovary: A retrospective study of seventy patients

AbstractIntroductionThis study aimed to describe the clinicopathological characteristics of recurrent adult granulosa cell tumor and identify the risk factors for recurrence.Material and methodsSeventy recurrent adult granulosa cell tumor patients treated in Peking Union Medical College Hospital between 2000 and 2020 were retrospectively reviewed. The primary outcomes were progression‐free survival after first recurrence (PFS‐R), overall survival after first recurrence (OS‐R) and recurrence frequency. The Kaplan–Meier analysis, univariate and multivariate Cox proportional hazard analysis, and the Prentice, Williams and Peterson counting process (PWP‐CP) model were adopted.ResultsThere were 70 patients included in the study, and recurrence occurred twice in more than 71% of patients, and 49.9% of patients relapsed ≥ three times. The recurrence pattern in over half of the patients at first recurrence was multifocal and distant disease, and abdominal or pelvic mass and liver metastasis were the most common. The 5‐year PFS‐R was 29.3%, and the 10‐year PFS‐R was 11.3%; the 5‐year OS‐R was 94.9%, and the 10‐year OS‐R was 87.9%. Kaplan–Meier analysis demonstrated that patients with distant recurrence and PFS1 (PFS when first recurrence occurred) ≤60 months had worse PFS‐R (p = 0.017, 0.018), and patients with PFS‐R ≤ 34 months had worse OS‐R (p = 0.023). It demonstrated that PFS1 ≤ 60 months (hazard ratio, HR 1.9, 95% confidence interval [CI]: 1.1–3.4, p = 0.028) was an independent risk factor for PFS‐R, and local lesion at recurrence (HR 0.488, 95% CI: 0.3–0.9, p = 0.027) was an independent protective factor for PFS‐R. In addition, it demonstrated that PFS‐R ≤ 33 months (HR 5.5, 95% CI: 1.2–25.3, p = 0.028) was an independent risk factor for OS‐R. The PWP‐CP analysis showed that laparoscopic operation (at each operation) could significantly increase recurrence times (p = 0.002, HR = 3.4), and no existence of gross residual lesion (R0) at each recurrence operation could significantly decrease recurrence frequency (p < 0.001, HR <0.001).ConclusionsThe recurrence pattern in patients with recurrent adult granulosa cell tumor was characterized as late and repeated, multifocal, and distant relapse. It has been demonstrated that PFS1 ≤ 60 months and distant lesion at recurrence are independent risk factors for PFS‐R, and PFS‐R ≤ 33 months is an independent risk factor for OS‐R. The PWP‐CP model showed that the transabdominal approach and surgery reaching R0 could significantly decrease the recurrence frequency.

Expression of B7 family checkpoint proteins in cervical cancer

The role of programmed cell death-ligand 1 (PD-L1) in cervical cancer has been widely investigated; however, the influences of other inhibitory B7 family members are poorly understood. We investigated the expression of PD-L1, B7 homolog 3 (B7-H3), B7-H4, and V-domain Ig suppressor of T-cell activation (VISTA) and their association with the clinicopathological features and outcomes of a large cohort of 673 patients with squamous cell carcinoma or adenocarcinoma of the uterine cervix. The positivity rates for PD-L1 (combined positive score ≥1), B7-H3 in tumor cells (TCs), B7-H4 (exclusively in TCs), VISTA in immune cells (ICs), and VISTA in TCs were 57.9%, 62.8%, 44.8%, 92.6%, and 4.8%, respectively, in 606 primary cervical cancer samples. Co-expression of PD-L1 with B7-H3 in TCs and with B7-H4 and VISTA in ICs was observed in 38.8%, 25.4%, and 57.9% of samples, respectively. B7-H3 in TCs and B7-H4 and VISTA in ICs were observed in 58.1%, 46.6%, and 83.1% of PD-L1-negative samples, respectively. These proteins were observed more frequently in squamous cell carcinomas and in moderately to poorly differentiated carcinomas. VISTA (in ICs) and B7-H4 were more frequent in primary tumors than in recurrent counterparts and correlated with improved survival; in contrast, B7-H3 positivity in TCs was less frequent in primary tumors and correlated with short disease-specific survival. Co-expression of B7-H4 and VISTA in ICs was an independent predictor of favorable outcomes overall and among patients with PD-L1-negative tumors. These data indicate that B7 family proteins exhibit differing expression patterns, distributions, and prognostic implications in cervical cancer. Furthermore, the co-expression of PD-L1 with other checkpoint proteins suggests that PD-1/PD-L1 blockade combined with modulating other immune checkpoints may present a novel therapeutic approach for cervical cancer. Future studies are needed to validate prognostic values of B7 family proteins and explore their biological roles in this malignancy.

21Works
2Papers
4Collaborators
PrognosisChoriocarcinomaGranulosa Cell TumorNeoplasm Recurrence, LocalOvarian NeoplasmsGenital Neoplasms, FemaleLeukemia, Myeloid, Acute

Education

2019

Post-graduate

Chinese Academy of Medical Sciences and Peking Union Medical College · Obstetrics and gynecology

Country

CN